Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian J Davis

Showing results (41-50 of 147) with videos related to

Pageof 15
Sort By:
International Journal of Radiation Oncology, Biology, Physics|April 26, 2011
Long-term outcomes after maximal surgical resection and intraoperative electron radiotherapy for locoregionally recurrent or locoregionally advanced primary renal cell carcinomaChristopher L Hallemeier, Richard Choo, Brian J Davis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 3, 2016
Improved Metastasis-Free and Survival Outcomes With Early Salvage Radiotherapy in Men With Detectable Prostate-Specific Antigen After Prostatectomy for Prostate CancerBradley J Stish, Thomas M Pisansky, William S Harmsen, et al.
European Urology|December 5, 2016
Reply from Authors re: Alberto Bossi, Nicolas Mottet, Pierre Blanchard. Choline Positron Emission Tomography/Computed Tomography for Selection of Patients for Salvage Strategies After Primary Local Treatment of Prostate Cancer and Rising Prostate-specific Antigen: Ready for Prime Time? Eur Urol 2017;71:349-50: C-11 Choline PET/CT and Guideline-directed CareWilliam P Parker, R Jeffrey Karnes, Lance A Mynderse, et al.
Practical Radiation Oncology|August 17, 2016
Detection of recurrent prostate cancer after primary radiation therapy: An evaluation of the role of multiparametric 3T magnetic resonance imaging with endorectal coilFabio Zattoni, Akira Kawashima, Alessandro Morlacco, et al.
Radiation Oncology (London, England)|July 31, 2014
Comparison of biochemical failure rates between permanent prostate brachytherapy and radical retropubic prostatectomy as a function of posttherapy PSA nadir plus 'X'Kamran A Ahmed, Brian J Davis, Lance A Mynderse, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 16, 2019
Current Status of MRI and PET in the NCCN Guidelines for Prostate CancerBrandon R Mason, James A Eastham, Brian J Davis, et al.
Journal of Contemporary Brachytherapy|November 30, 2016
Predictors of prostate volume reduction following neoadjuvant cytoreductive androgen suppressionKrishan R Jethwa, Keith M Furutani, Lance A Mynderse, et al.
Nature Reviews. Urology|July 1, 2017
The evolution of brachytherapy for prostate cancerNicholas G Zaorsky, Brian J Davis, Paul L Nguyen, et al.
The Journal of Urology|May 10, 2005
Urinary fistulas following external radiation or permanent brachytherapy for the treatment of prostate cancerKristin L Chrouser, Bradley C Leibovich, Susan D Sweat, et al.
Cancer|September 5, 2002
The relevance of prostatectomy findings for brachytherapy selection in patients with localized prostate carcinomaThomas M Pisansky, Michael L Blute, David W Hillman, et al.
Pageof 15

Showing results (41-50 of 147) with videos related to

Sort By:
Pageof 15
International Journal of Radiation Oncology, Biology, Physics|April 26, 2011
Long-term outcomes after maximal surgical resection and intraoperative electron radiotherapy for locoregionally recurrent or locoregionally advanced primary renal cell carcinomaChristopher L Hallemeier, Richard Choo, Brian J Davis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 3, 2016
Improved Metastasis-Free and Survival Outcomes With Early Salvage Radiotherapy in Men With Detectable Prostate-Specific Antigen After Prostatectomy for Prostate CancerBradley J Stish, Thomas M Pisansky, William S Harmsen, et al.
European Urology|December 5, 2016
Reply from Authors re: Alberto Bossi, Nicolas Mottet, Pierre Blanchard. Choline Positron Emission Tomography/Computed Tomography for Selection of Patients for Salvage Strategies After Primary Local Treatment of Prostate Cancer and Rising Prostate-specific Antigen: Ready for Prime Time? Eur Urol 2017;71:349-50: C-11 Choline PET/CT and Guideline-directed CareWilliam P Parker, R Jeffrey Karnes, Lance A Mynderse, et al.
Practical Radiation Oncology|August 17, 2016
Detection of recurrent prostate cancer after primary radiation therapy: An evaluation of the role of multiparametric 3T magnetic resonance imaging with endorectal coilFabio Zattoni, Akira Kawashima, Alessandro Morlacco, et al.
Radiation Oncology (London, England)|July 31, 2014
Comparison of biochemical failure rates between permanent prostate brachytherapy and radical retropubic prostatectomy as a function of posttherapy PSA nadir plus 'X'Kamran A Ahmed, Brian J Davis, Lance A Mynderse, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 16, 2019
Current Status of MRI and PET in the NCCN Guidelines for Prostate CancerBrandon R Mason, James A Eastham, Brian J Davis, et al.
Journal of Contemporary Brachytherapy|November 30, 2016
Predictors of prostate volume reduction following neoadjuvant cytoreductive androgen suppressionKrishan R Jethwa, Keith M Furutani, Lance A Mynderse, et al.
Nature Reviews. Urology|July 1, 2017
The evolution of brachytherapy for prostate cancerNicholas G Zaorsky, Brian J Davis, Paul L Nguyen, et al.
The Journal of Urology|May 10, 2005
Urinary fistulas following external radiation or permanent brachytherapy for the treatment of prostate cancerKristin L Chrouser, Bradley C Leibovich, Susan D Sweat, et al.
Cancer|September 5, 2002
The relevance of prostatectomy findings for brachytherapy selection in patients with localized prostate carcinomaThomas M Pisansky, Michael L Blute, David W Hillman, et al.
Pageof 15